FDA Reverses Course On Convalescent Plasma Treatment For COVID-19

Name: FDA Reverses Course On Convalescent Plasma Treatment For COVID-19
Uploaded: 2020-08-24T03:25:12+00:00
Duration: P147S
Description: President Trump applauded the agency's emergency authorization during his press conference on Sunday. CBS2's Ali Bauman reports

Video Credit: CBS 2 New York - Duration: 02:27s - Published on August 24, 2020

FDA Reverses Course On Convalescent Plasma Treatment For COVID-19

President Trump applauded the agency's emergency authorization during his press conference on Sunday.

CBS2's Ali Bauman reports

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Doctor details risks of plasma treatment for COVID-19 [Video]

Doctor details risks of plasma treatment for COVID-19

Doctors are reacting to the announcement by the Food and Drug Administration that it will authorize emergency use of convalescent plasma to treat COVID-19.

Credit: KSWB Duration: 01:57Published on August 25, 2020

Convalescent Plasma study

Blood Assurance will study Convalescent Plasma as a Covid-19 treatment after the Trump Administration gave the go-ahead over the weekend.

Credit: WDEF CBS Chattanooga, TNPublished on August 25, 2020

FDA Chief Refutes Trump’s Baseless Claim That ‘Deep State’ Is Slowing Vaccine Development [Video]

FDA Chief Refutes Trump’s Baseless Claim That ‘Deep State’ Is Slowing Vaccine Development

The head of the FDA refuted baseless claims by President Trump that a “deep state” was preventing coronavirus vaccine development until after the election. Veuer’s Justin Kircher has the story.

Credit: Veuer Duration: 01:01Published on August 25, 2020

FDA Reverses Course On Convalescent Plasma Treatment For COVID-19

You Might Like

Related videos from verified sources